IRIS UniCatt

Giampietro, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.811
NA - Nord America 2.653
AS - Asia 1.248
SA - Sud America 418
AF - Africa 43
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.184
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.593
DE - Germania 1.102
SG - Singapore 444
CN - Cina 420
SE - Svezia 409
BR - Brasile 375
IT - Italia 353
UA - Ucraina 180
FR - Francia 177
GB - Regno Unito 122
IE - Irlanda 120
ID - Indonesia 84
FI - Finlandia 81
IN - India 77
RU - Federazione Russa 74
PL - Polonia 68
VN - Vietnam 39
CA - Canada 34
BE - Belgio 25
NL - Olanda 25
HK - Hong Kong 23
TR - Turchia 23
AT - Austria 21
BD - Bangladesh 19
IQ - Iraq 18
KR - Corea 18
ES - Italia 15
IR - Iran 14
JP - Giappone 14
MX - Messico 13
AR - Argentina 12
ZA - Sudafrica 10
CI - Costa d'Avorio 9
VE - Venezuela 9
CZ - Repubblica Ceca 7
PK - Pakistan 7
UZ - Uzbekistan 7
CO - Colombia 6
LK - Sri Lanka 6
PT - Portogallo 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
EG - Egitto 5
MA - Marocco 5
AL - Albania 4
AZ - Azerbaigian 4
JM - Giamaica 4
JO - Giordania 4
PY - Paraguay 4
AU - Australia 3
BG - Bulgaria 3
CH - Svizzera 3
ET - Etiopia 3
EU - Europa 3
KE - Kenya 3
MD - Moldavia 3
PE - Perù 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
GH - Ghana 2
GR - Grecia 2
HN - Honduras 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
OM - Oman 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CL - Cile 1
DK - Danimarca 1
GE - Georgia 1
GU - Guam 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
ML - Mali 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
RS - Serbia 1
SC - Seychelles 1
TH - Thailandia 1
Totale 7.184
Salva come PNG Salva come JPEG
Città #
Chandler 582
Singapore 287
Ashburn 145
New York 117
Dublin 112
San Mateo 108
Rome 93
Ann Arbor 82
Jakarta 81
Munich 74
Jacksonville 72
Fairfield 68
Wilmington 68
Marseille 61
Milan 57
Warsaw 57
Boston 56
Nürnberg 55
Los Angeles 49
Nanjing 48
Moscow 47
The Dalles 45
Bremen 44
Seattle 41
Cattolica 40
Princeton 40
Hefei 38
Frankfurt am Main 37
Dearborn 34
Houston 34
Helsinki 33
Redwood City 31
Woodbridge 29
Chicago 26
São Paulo 26
Brussels 24
Nanchang 24
Cambridge 23
Shanghai 23
Beijing 21
Hangzhou 21
Hong Kong 21
Lawrence 21
Boardman 20
Mountain View 20
London 19
Zhengzhou 19
Hyderabad 17
Nuremberg 17
University Park 17
Turku 16
North Bergen 15
Seoul 15
Shenyang 15
Fremont 14
Hanoi 14
Guangzhou 13
Augusta 12
Belo Horizonte 12
Bexley 12
Düsseldorf 12
Montreal 12
Norwalk 12
Rio de Janeiro 12
Vienna 12
Kunming 11
Lauterbourg 11
Leawood 11
Hebei 10
Izmir 10
Santa Clara 10
Abidjan 9
Ho Chi Minh City 9
Kish 9
Portsmouth 9
Redmond 9
Brooklyn 8
Changsha 8
Lancaster 8
Mumbai 8
Toronto 8
Baghdad 7
Brescia 7
Colombo 7
Mexico City 7
Piacenza 7
Porto Alegre 7
Pune 7
Tashkent 7
Tianjin 7
Washington 7
Andover 6
Canterbury 6
Jiaxing 6
Paris 6
West Jordan 6
Wroclaw 6
Amsterdam 5
Dallas 5
Menlo Park 5
Totale 3.591
Salva come PNG Salva come JPEG
Nome #
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 247
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 247
Double pituitary adenomas 202
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 172
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 163
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 162
Role of a mini-invasive approach in the diagnosis and treatment of tubo-peritoneal infertility as an altenative to IVF [Il ruolo di un approccio chirurgico mini-invasivo nella diagnosi e trattamento della sterilità tubo-peritoneale in alternativa alla FIVET] 161
Male fertility and reduction in semen parameters: A single tertiary-care center experience 160
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 154
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 149
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 147
NOVEL BIOMARKERS OF ANDROGEN DEFICIENCY FROM SEMINAL PLASMA PROFILING USING HIGH-RESOLUTION MASS SPECTROMETRY. 143
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study 132
Isolated growth hormone deficiency: clinical entity? 125
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 125
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 123
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 120
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 116
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 115
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 115
The Changing Clinical Spectrum of Hypophysitis 115
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 112
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 108
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 108
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 106
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 106
Fertility and hypopituitarism 102
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 98
GH receptor isoforms and skeletal fragility in acromegaly 96
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 93
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 91
Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry 84
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 84
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 78
Quantitative Analysis of the Seminal Plasma Proteome in Secondary Hypogonadism 77
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 76
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 76
Vertebral fractures in patients with acromegaly: a 3-year prospective study 75
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 75
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 75
Empty sella syndrome: Multiple endocrine disorders. 73
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 73
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 71
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 71
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 70
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 69
Understanding the effect of acromegaly on the human skeleton. 68
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 68
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 67
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 66
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 65
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 63
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 62
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 60
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 59
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 58
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 58
Solitary Metastatic Melanoma of the Pituitary Gland: Report of Two Cases and Literature Review 57
Acromegaly in the elderly patients 54
Hypothalamitis and pituitary atrophy 54
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 53
Acromegaly can be cured by first-line pasireotide treatment? 52
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 52
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 49
Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study 49
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 45
Bone safety of dual-release hydrocortisone in patients with hypopituitarism. 44
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 41
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 39
Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case 38
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 37
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 36
De-escalation treatment with pasireotide for acromegaly: a long-term experience 34
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 33
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 29
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 28
Second line treatment of acromegaly: Pasireotide or Pegvisomant? 27
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience 26
Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study 25
IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly 24
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy 24
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries 24
Pregnancy in Autoimmune Hypophysitis: Management of a Rare Condition 24
Genes of the “regulation of lymphocyte activation” pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors 22
Empty sella syndrome: an update 22
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 22
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 21
The Differential Diagnosis between Pseudo Cushing's Syndrome and True Cushing's Syndrome in a Septic Patient in the Pre-Agonal Phase: A Case Report 20
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 19
Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma 19
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 17
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 15
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 15
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly 15
GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot study 14
Cytokines and chemokines modulate the growth of pituitary adenoma/neuroendocrine tumors: preliminary results of a monocenter prospective pilot study 13
Clinical implications of the 2022 WHO classification on the multidisciplinary management of PitNETS patients 12
Vitamin D in pituitary driven osteopathies 11
A Toluene-induced Infundibulo-neuro-hypophysitis: Presentation of a New Cause of Hypophysitis Secondary to Toxic Exposure and Review on Toluene Inhalation Endocrine Effects 8
Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences 8
Totale 7.305
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021419 20 42 11 42 50 27 47 9 43 55 68 5
2021/2022617 30 33 7 47 74 27 10 112 28 26 85 138
2022/20231.516 173 207 123 252 80 211 89 127 157 13 53 31
2023/2024717 32 160 17 32 31 142 35 8 28 34 93 105
2024/20251.856 30 40 124 75 101 74 37 67 273 188 400 447
2025/2026360 360 0 0 0 0 0 0 0 0 0 0 0
Totale 7.309